LON:FUM Futura Medical (FUM) Share Price, News & Analysis → Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad) Free FUM Stock Alerts GBX 35.16 +0.91 (+2.64%) (As of 06:42 AM ET) Add Compare Share Share Today's Range 34.70▼ 35.3550-Day Range 32.90▼ 42.8052-Week Range 23.28▼ 67Volume187,099 shsAverage Volume753,311 shsMarket Capitalization£105.97 millionP/E RatioN/ADividend Yield4.55%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Futura Medical alerts: Email Address Ad Warrior Life(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” Most citizens don’t… but according to my friend (and best-selling survival author), Jeff, even the hardcore “preppers” who cherish their bug-out bags are doing it all wrong!All the details are right here… About Futura Medical Stock (LON:FUM)Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.Read More FUM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FUM Stock News HeadlinesMay 3, 2024 | morningstar.comFutura Medical PLC FUMMay 1, 2024 | finance.yahoo.comAnalysts Expect Breakeven For Futura Medical plc (LON:FUM) Before LongApril 11, 2024 | finance.yahoo.comFutura Medical targets global expansion with Eroxon, eyeing profitability in 2024March 14, 2024 | finance.yahoo.comFutura Medical plc (FUM.L)March 13, 2024 | finance.yahoo.comThose who invested in Futura Medical (LON:FUM) five years ago are up 175%February 6, 2024 | msn.comFutura Medical shares swell as sales of erectile dysfunction gel boomJanuary 31, 2024 | lse.co.ukFutura Medical Share ChatJanuary 29, 2024 | finance.yahoo.comWith 59% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big gunsNovember 8, 2023 | msn.comM8 to market Futura’s erectile dysfunction gel in more countriesNovember 7, 2023 | finance.yahoo.comFutura Medical continues global expansion with Latin America announcementNovember 3, 2023 | finance.yahoo.comHere's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn SituationOctober 19, 2023 | proactiveinvestors.comFutura Medical hails first UAE stockist of ED treatmentOctober 19, 2023 | proactiveinvestors.comFutura Medical ED drug roll continues apaceOctober 5, 2023 | finance.yahoo.comFutura Medical's (LON:FUM) investors will be pleased with their strong 256% return over the last five yearsOctober 2, 2023 | marketwatch.comFutura Medical Gets European Patent for Erectile Dysfunction TreatmentOctober 2, 2023 | proactiveinvestors.comFutura Medical secures European patent protection for ED gel out to 2040September 18, 2023 | proactiveinvestors.com.auFutura Medical targets profitability as erectile dysfunction gel gains commercial tractionSeptember 18, 2023 | proactiveinvestors.comFutura Medical: Pieces of the jigsaw falling into place, says...August 22, 2023 | finance.yahoo.comWith 58% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big gunsJuly 18, 2023 | proactiveinvestors.comFutura Medical "absolutely delighted" with US commercialisation agreementJune 22, 2023 | proactiveinvestors.comFutura Medical says early sales of erectile dysfunction gel...Futura Medical says early sales of erectile dysfunction gel met...June 13, 2023 | markets.businessinsider.comFutura Granted FDA Approval For OTC Marketing Of MED3000 Gel For Erectile DysfunctionJune 13, 2023 | uk.finance.yahoo.comFAMDF - Futura Medical plcJune 12, 2023 | finance.yahoo.comUS FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile DysfunctionJune 12, 2023 | proactiveinvestors.comFutura Medical shares jump 22% in the wake of FDA green lightSee More Headlines Receive FUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/16/2020Today6/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:FUM CUSIPN/A CIKN/A Webwww.futuramedical.com Phone+44-1483-685670FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-6,510,000.00 Net Margins-210.03% Pretax MarginN/A Return on Equity-127.75% Return on Assets-47.60% Debt Debt-to-Equity RatioN/A Current Ratio1.47 Quick Ratio5.73 Sales & Book Value Annual Sales£3.10 million Price / Sales33.89 Cash FlowGBX 1.71 per share Price / Cash Flow20.43 Book ValueGBX 2 per share Price / Book17.43Miscellaneous Outstanding Shares301,450,000Free FloatN/AMarket Cap£105.06 million OptionableNot Optionable Beta1.28 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. James Henry Barder (Age 65)CEO & Executive Director Comp: $397.08kMs. Angela Hildreth (Age 44)COO, Finance Director, Company Secretary & Executive Director Comp: $310.8kMr. Kenneth William James (Age 72)Head of R&D & Executive Director Comp: $284.59kDr. William Duncan Potter (Age 76)Chief Scientific Officer & Adviser to the Board Graham SmithHead of Alliance Partnerships & SupplyKevin LangridgeHead of QualityMore ExecutivesKey CompetitorsOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDVerona Pharma plc (VRP.L)LON:VRP4basebioLON:4BBBioventixLON:BVXPView All Competitors FUM Stock Analysis - Frequently Asked Questions How have FUM shares performed in 2024? Futura Medical's stock was trading at GBX 25.50 at the start of the year. Since then, FUM stock has increased by 38.6% and is now trading at GBX 35.34. View the best growth stocks for 2024 here. How were Futura Medical's earnings last quarter? Futura Medical plc (LON:FUM) posted its quarterly earnings data on Wednesday, September, 16th. The company reported ($0.44) earnings per share (EPS) for the quarter. Futura Medical had a negative trailing twelve-month return on equity of 127.75% and a negative net margin of 210.03%. What other stocks do shareholders of Futura Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS). How do I buy shares of Futura Medical? Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:FUM) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.